BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  Merck’s Keytruda Fails in Late-Stage HCC Trial

  Keytruda failed to show a statistical significance in overall survival and progression free survival in the Phase III trial.

  February 20, 2019

   · 

  2 min read

   · 

  Alex Keown
• Policy

  SD Mines Hosts Student Research Opportunities

  Undergraduate students from around the country will get real-world research experience this summer while participating in Research Experience for Undergraduates programs and other research opportunities on the campus of South Dakota School of Mines & Technology.

  February 20, 2019

   · 

  3 min read
• 

  Drug Development

  FDA Places Partial Clinical Hold on Xencor Clinical Trial Following Two Patient Deaths

  The patients were part of a trial assessing Xencor’s mAb14045, a CD123 x CD3 bispecific antibody molecule being evaluated in patients with relapsed or refractory acute myeloid leukemia.

  February 20, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Fast Company Selects Biotech Companies as Part of Its 2019 List of Innovative Companies

  For its 2019 list of the top 50 most innovative companies, Fast Company selected 10 from the biotech industry that are having a significant impact on the treatment of patients. The first five are highlighted.

  February 20, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Could Great White Shark DNA Hold a Secret to Curing Cancer?

  Cue the John Williams theme to the movie Jaws and make sure you have a big enough boat as we dive into this story. New research shows that great white sharks may actually hold some secrets when it comes to potential cures for cancer.

  February 20, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  BioSpace’s Global Biopharma Roundup: February 21

  Lots of interesting biotech news from Asia, Europe and elsewhere was reported this week. From tapeworms to using a breathalyzer test in lung cancer diagnostics, the global biotech industry is exploding with ideas.

  February 20, 2019

   · 

  4 min read

   · 

  Alex Keown
• 

  10 Highly Effective Ways to Instantly Lower Your Stress Levels on the Job

  Excessive stress in the workplace can have devastating effects on your productivity and job satisfaction levels, your performance, and your overall health and wellbeing.

  February 20, 2019

   · 

  4 min read

   · 

  Editorial Staff
• 

  Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory Epilepsy

  With Official Launch and First Implant, Several Health Insurers Now Consider

  February 20, 2019

   · 

  5 min read
• 

  Policy

  Research Shows Many Patients Were Improperly Prescribed Fentanyl

  The study found that the majority of patients who were given the powerful painkiller did not have cancer or pain associated with the disease, which is what the drug is indicated to help.

  February 20, 2019

   · 

  2 min read

   · 

  Alex Keown
• Drug Development

  ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

  Combination trial to evaluate safety and anti-tumor activity of agents that target B-cell cancers

  February 20, 2019

   · 

  5 min read